Therapy-Related Myelodysplastic Syndrome Recruiting Phase 1 Trials for Fludarabine (DB01073)

IndicationStatusPhase
DBCOND0079186 (Therapy-Related Myelodysplastic Syndrome)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02960646Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment